| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Norio Yasui-Furukori, Hanako Furukori, Norio Sugawara, Akira Fujii, Sunao Kanek. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814333. |
dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Norio Yasui-Furukori, Hanako Furukori, Norio Sugawara, Akira Fujii, Sunao Kanek. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814333. |
aripiprazole was concomitantly administrated to 16 female patients with schizophrenia receiving 2 to 15 mg/d of risperidone. |
2011-08-08 |
2023-08-12 |
Not clear |
| Chi-Un Pae, Andy Forbes, Ashwin A Patka. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS drugs. vol 25. issue 2. 2011-07-29. PMID:21254788. |
aripiprazole was initially approved to treat schizophrenia and later approved for bipolar mania, as a monotherapy and an adjunctive therapy (manic or mixed episodes), and for irritability associated with autism. |
2011-07-29 |
2023-08-12 |
Not clear |
| Armida Mucci, Giuseppe Piegari, Silvana Galderis. Cognitive-enhancing effects of aripiprazole: a case report. Clinical practice and epidemiology in mental health : CP & EMH. vol 4. 2011-07-14. PMID:18959801. |
before schizophrenia onset his cognitive functioning was poor and he could not attend regular courses to reach his high school degree; he started but was not able to attend the university courses for several years.after schizophrenia onset, he was treated, in sequence, with olanzapine, amisulpride and aripiprazole. |
2011-07-14 |
2023-08-12 |
Not clear |
| Ming-Hong Hsieh, Wei-Wen Lin, Shao-Tsu Chen, Kao-Ching Chen, Kuang-Peng Chen, Nan-Ying Chiu, Chao Huang, Ching-Jui Chang, Cheng-Hsiu Lin, Te-Jen La. A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. Annals of general psychiatry. vol 9. 2011-07-14. PMID:20849577. |
a 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. |
2011-07-14 |
2023-08-12 |
Not clear |
| Ming-Hong Hsieh, Wei-Wen Lin, Shao-Tsu Chen, Kao-Ching Chen, Kuang-Peng Chen, Nan-Ying Chiu, Chao Huang, Ching-Jui Chang, Cheng-Hsiu Lin, Te-Jen La. A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. Annals of general psychiatry. vol 9. 2011-07-14. PMID:20849577. |
to evaluate the overall long-term effectiveness of aripiprazole in patients with schizophrenia in a general psychiatric practice setting in taiwan. |
2011-07-14 |
2023-08-12 |
Not clear |
| Yoram Barak, Dov Aizenber. Switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophrenia. Journal of obesity. vol 2011. 2011-07-14. PMID:20871835. |
switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Mirjana Carli, Eleonora Calcagno, Pierangela Mainolfi, Ester Mainini, Roberto W Invernizz. Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology. vol 214. issue 3. 2011-07-14. PMID:21052982. |
effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. |
2011-07-14 |
2023-08-12 |
rat |
| Adam Keller Ashto. Aripiprazole augmentation of clozapine: in refractory schizophrenia. Psychiatry (Edgmont (Pa. : Township)). vol 2. issue 2. 2011-07-14. PMID:21179630. |
aripiprazole augmentation of clozapine: in refractory schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Wayne Macfadden, Yi-Wen Ma, J Thomas Haskins, Cynthia A Bossie, Larry Alph. A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont (Pa. : Township)). vol 7. issue 11. 2011-07-14. PMID:21191530. |
a prospective study comparing the long-term effectiveness of injectable risperidone long-acting therapy and oral aripiprazole in patients with schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Wayne Macfadden, Yi-Wen Ma, J Thomas Haskins, Cynthia A Bossie, Larry Alph. A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont (Pa. : Township)). vol 7. issue 11. 2011-07-14. PMID:21191530. |
to test the hypothesis that long-term maintenance with injectable risperidone long-acting therapy is superior to oral daily aripiprazole in stable patients with schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| A Sarin, J Nagpal, N K Bohra, R C Jiloha, G P Rao, S K Sharma, M Vaishnav, L Vaya, R S Karan, N K Patel, R Pate. Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia. Indian journal of psychiatry. vol 46. issue 1. 2011-07-14. PMID:21206777. |
open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of indian patients of schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| A Sarin, J Nagpal, N K Bohra, R C Jiloha, G P Rao, S K Sharma, M Vaishnav, L Vaya, R S Karan, N K Patel, R Pate. Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia. Indian journal of psychiatry. vol 46. issue 1. 2011-07-14. PMID:21206777. |
based on various short term and long term studies, aripiprazole has been found to be effective in schizophrenia and has no significant adverse effect on qtc prolongation, prolactin, serum lipids, and has a low potential for weight gain. |
2011-07-14 |
2023-08-12 |
Not clear |
| A Sarin, J Nagpal, N K Bohra, R C Jiloha, G P Rao, S K Sharma, M Vaishnav, L Vaya, R S Karan, N K Patel, R Pate. Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia. Indian journal of psychiatry. vol 46. issue 1. 2011-07-14. PMID:21206777. |
present study aims to evaluate the efficacy and tolerability of aripiprazole (10-15mg/day) in the treatment of indian patients of schizophrenia and to see its effect on qtc interval, prolactin levels, serum lipids, plasma sugar and weight gain in these patients. |
2011-07-14 |
2023-08-12 |
Not clear |
| A Sarin, J Nagpal, N K Bohra, R C Jiloha, G P Rao, S K Sharma, M Vaishnav, L Vaya, R S Karan, N K Patel, R Pate. Open labeled, randomized, switch-over study of two fixed doses (10/15mg) of aripiprazole : to evaluate its safety and efficacy in the treatment of Indian patients of schizophrenia. Indian journal of psychiatry. vol 46. issue 1. 2011-07-14. PMID:21206777. |
outpatients with an ongoing/newly diagnosed icd-10 schizophrenia (n=136) were randomly assigned to 10 or 15 mg dose of aripiprazole for a period of six weeks. |
2011-07-14 |
2023-08-12 |
Not clear |
| Chittaranjan Andrad. Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders. Indian journal of psychiatry. vol 46. issue 3. 2011-07-14. PMID:21224917. |
efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. |
2011-07-14 |
2023-08-12 |
Not clear |
| R K Chavda, L Laxmi, B S Nair, K Gandewa. Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. Indian journal of psychiatry. vol 46. issue 2. 2011-07-14. PMID:21408042. |
efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. |
2011-07-14 |
2023-08-12 |
Not clear |
| R K Chavda, L Laxmi, B S Nair, K Gandewa. Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. Indian journal of psychiatry. vol 46. issue 2. 2011-07-14. PMID:21408042. |
aripiprazole is a study drug for treating schizophrenia and has a novel pharmacologic profile. |
2011-07-14 |
2023-08-12 |
Not clear |
| R K Chavda, L Laxmi, B S Nair, K Gandewa. Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders. Indian journal of psychiatry. vol 46. issue 2. 2011-07-14. PMID:21408042. |
aripiprazole, effective against positive and negative symptoms, is a safe and well-tolerated potential treatment for schizophrenia and schizoaffective disorder. |
2011-07-14 |
2023-08-12 |
Not clear |
| Che-Lin Yueh, Sung-Lin Yu, Hsiao-Min Chen, Bo-Jian Wu, Wen-Ching Che. Aripiprazole-induced seizure: a second case report. BMJ case reports. vol 2009. 2011-07-14. PMID:21754963. |
the present report concerns a 54-year-old man with chronic schizophrenia who developed a witnessed grand mal seizure after he had abruptly discontinued clozapine and benzodiazepam (bzd) treatment and concurrently reinitiated aripiprazole treatment as the result of an involuntary clinical error. |
2011-07-14 |
2023-08-12 |
Not clear |